Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amylyx Pharmaceuticals
Biotech
FDA lifts clinical hold on Amylyx ALS trial
The trial represents Amylyx's latest effort in ALS after last year’s market withdrawal of Relyvrio.
Gabrielle Masson
Jan 21, 2025 10:35am
Amylyx preps for GLP-1 launch with new CCO—Chutes & Ladders
Jan 10, 2025 8:30am
Amylyx CEOs take hard lessons to rebuild the pipeline
Jul 10, 2024 7:00am
Amylyx seeks to fill Relyvrio-sized hole with $35M GLP-1 buy
Jun 24, 2024 10:18am
Amylyx stock slips 6% after phase 2 rare disease data drop
Apr 10, 2024 2:48pm
Seelos' sugar therapy fails to improve ALS severity in ph. 2/3
Mar 19, 2024 10:00am
